Experience

• • Clayton, Dubilier & Rice in its $2.9 billion acquisition of White Cap, a leading distributor of specialty concrete and construction products, and its combination of White Cap with CSG, a leading U.S. distributor of specialty concrete and masonry accessories, for a total transaction value of approximately $4 billion.
  • Prudential plc and Jackson National in the reinsurance to Athene of $27.6 billion of Jackson’s in-force fixed and fixed index annuities and a $500 million equity investment in Jackson’s holding company.
  • Clayton, Dubilier & Rice in its $250 million convertible preferred equity investment in Covetrus, a global leader in animal-health technology and services.
  • J.C. Flowers and AmeriLife Group in the sale of AmeriLife to Thomas H. Lee Partners.
  • Clayton, Dubilier & Rice in its acquisition of Cynosure, a leader in medical aesthetics systems and technologies, from Hologic, a NASDAQ listed medical technology company primarily focused on women’s health.
  • DoubleVerify in its acquisition of Ad-Juster, a market-leading SaaS provider of unified data reporting and analytics for digital advertising.
  • Kelso & Company in its acquisition of a majority equity interest in Individual FoodService from Sole Source Capital.
  • OEConnection (OEC) and Providence Equity in the sale of a majority stake in OEC to Genstar Capital.
  • One Rock Capital Partners in its acquisition of the Engineered Components and Systems segment of Actuant Corporation.
  • Vinci Partners in the formation of Vinci Capital Partners Fund III, a $1 billion private equity fund program.
  • Chubb in its long-term distribution agreement with Banco de Chile, the largest bank based in Chile.
  • AXA and AXA Equitable Holdings on the initial public offering of AXA Equitable Holdings on the New York Stock Exchange for approximately $4 billion, and AXA Equitable Holdings in its offering and sale of $3.8 billion of senior notes.
  • Citizens Financial in its acquisition of Franklin American Mortgage.
  • Nationstar Mortgage, a leading mortgage servicer and originator, in its $3.8 billion merger with WMIH.
  • Sawai Pharmaceutical in the sale of a minority stake of its U.S. subsidiary, Upsher-Smith Laboratories, to Japanese trading house Sumitomo.
  • Sawai Pharmaceutical in its $1.5 billion acquisition of the generic pharmaceuticals business of Upsher-Smith Laboratories.